MeSH tree: D12.776.124.790.651.114.224.060
Viral infections that attack the lungs are among the leading reasons infants are hospitalized. A new treatment may offer protection against these infections that is as effective and safe as existing options but requires far ...
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular ...
Jul 15, 2026
0
8
An international team led by the Josep Carreras Leukaemia Research Institute (IJC) in Barcelona, the Centre for Genomics and Oncological Research (GENyO) and the University of Granada (UGR) has identified a new biological ...
Jul 14, 2026
0
4
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival ...
Jul 7, 2026
0
6
It's common knowledge that ticks can spread infections that cause serious illnesses, including Lyme disease. Now health officials are trying to raise awareness of a lesser-known problem: a life-threatening allergy to meat ...
Jun 15, 2026
0
7
Modern breast cancer screening and treatment have transformed survival. Many women now live long and healthy lives after diagnosis, thanks to increasingly effective chemotherapy and targeted therapies: medicines designed ...
Jun 13, 2026
0
21
Scientists have made great progress in harnessing the body's own immune cells to treat so-called liquid tumors, cancers of the blood and lymphatic system. Yet these powerful cell therapies have been no match for solid tumors, ...
Jun 11, 2026
0
12
HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave.
Jun 8, 2026
0
6
The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the neoadjuvant and adjuvant treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive ...
May 25, 2026
0
10
A Phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment. Researchers at Sylvester Comprehensive ...
May 21, 2026
0
4
